Frontiers in nutrition · 2026
Can live microbial interventions support healthy aging? A systematic review and meta-analysis of cognitive and muscle outcomes in aging adults.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Silva-Olivares Francisco, Vidal Nicole, Acevedo-Hernández Paula, Rabbia Virginia, Petermann-Rocha Fanny, Thomas-Valdés Samanta, Jorquera Gonzalo
Аннотация
INTRODUCTION: Preserving cognitive and physical function is central to healthy aging, and the gut microbiota may influence both brain and muscle physiology. We evaluated whether live microorganism-based interventions affect cognitive and muscle-related outcomes in aging adults.
METHODS: We systematically reviewed randomized placebo-controlled trials of probiotics, synbiotics, or fecal microbiota transplantation in populations with a mean age of at least 60 years. MEDLINE, Embase, Web of Science, and the Cochrane Library were searched. Random-effects meta-analyses used Hedges' g when at least three studies or independent comparisons reported sufficiently comparable outcomes. The protocol was prospectively registered in PROSPERO (CRD420251065993; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251065993).
RESULTS: Twenty-four trials involving 1,809 participants were included qualitatively: 20 evaluated cognitive outcomes and four evaluated muscle-related outcomes. Eleven unique studies contributed to at least one meta-analysis. For Mini-Mental State Examination scores, the overall pooled estimate was positive (g = 1.02; 95% CI: 0.36-1.68; I 2 = 90.84%). In exploratory post hoc subgroup analyses, the estimate was positive in Alzheimer's disease (g = 1.46; 95% CI: 1.14-1.79) but not statistically significant in broader cognitive impairment (g = 0.49; 95% CI: -0.78 to 1.77); the subgroup difference was not significant (p = 0.15). Excluding both Akhgarjand et al. intervention arms yielded a positive estimate in Alzheimer's disease (g = 1.63; 95% CI: 1.21-2.06), although only two studies remained. The pooled Repeatable Battery for the Assessment of Neuropsychological Status result was not statistically significant (g = 0.46; 95% CI: -0.50 to 1.41). Handgrip strength showed a modest positive estimate (g = 0.46; 95% CI: 0.06-0.85), but exclusion of Qaisar et al. attenuated it to non-significance (g = 0.23; 95% CI: -0.27 to 0.73).
DISCUSSION: Live microorganism-based interventions showed preliminary short-term functional signals, but the small evidence base, high cognitive heterogeneity, short follow-up, and sensitivity to individual studies preclude firm efficacy conclusions. Subgroup and two-study sensitivity findings are exploratory. No eligible fecal microbiota transplantation trial was identified, so the evidence derives exclusively from probiotic and synbiotic studies.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251065993, unique identifier: CRD420251065993.
METHODS: We systematically reviewed randomized placebo-controlled trials of probiotics, synbiotics, or fecal microbiota transplantation in populations with a mean age of at least 60 years. MEDLINE, Embase, Web of Science, and the Cochrane Library were searched. Random-effects meta-analyses used Hedges' g when at least three studies or independent comparisons reported sufficiently comparable outcomes. The protocol was prospectively registered in PROSPERO (CRD420251065993; https://www.crd.york.ac.uk/PROSPERO/view/CRD420251065993).
RESULTS: Twenty-four trials involving 1,809 participants were included qualitatively: 20 evaluated cognitive outcomes and four evaluated muscle-related outcomes. Eleven unique studies contributed to at least one meta-analysis. For Mini-Mental State Examination scores, the overall pooled estimate was positive (g = 1.02; 95% CI: 0.36-1.68; I 2 = 90.84%). In exploratory post hoc subgroup analyses, the estimate was positive in Alzheimer's disease (g = 1.46; 95% CI: 1.14-1.79) but not statistically significant in broader cognitive impairment (g = 0.49; 95% CI: -0.78 to 1.77); the subgroup difference was not significant (p = 0.15). Excluding both Akhgarjand et al. intervention arms yielded a positive estimate in Alzheimer's disease (g = 1.63; 95% CI: 1.21-2.06), although only two studies remained. The pooled Repeatable Battery for the Assessment of Neuropsychological Status result was not statistically significant (g = 0.46; 95% CI: -0.50 to 1.41). Handgrip strength showed a modest positive estimate (g = 0.46; 95% CI: 0.06-0.85), but exclusion of Qaisar et al. attenuated it to non-significance (g = 0.23; 95% CI: -0.27 to 0.73).
DISCUSSION: Live microorganism-based interventions showed preliminary short-term functional signals, but the small evidence base, high cognitive heterogeneity, short follow-up, and sensitivity to individual studies preclude firm efficacy conclusions. Subgroup and two-study sensitivity findings are exploratory. No eligible fecal microbiota transplantation trial was identified, so the evidence derives exclusively from probiotic and synbiotic studies.
SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251065993, unique identifier: CRD420251065993.